跳至主要内容
临床试验/NCT04831918
NCT04831918已完成不适用

A Prospective Clinical Study Evaluating Clinical, Radiographic And Patient-Reported Outcomes Of THA With Cemented Acetabular Cups

Limacorporate S.p.a2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
2
主要终点
Clinical progression of Harris Hip Score (HHS) from baseline to 2 years after surgery

研究概览

简要总结

This clinical study has the aim to evaluate clinical, radiographic, patient-reported outcomes of total hip arthroplasty with the implant of Mueller cemented acetabular cups up to 2 years after surgery, in order to assess the performance of the device. Furthermore, it aims to collect short-term survivorship of the implant and the incidence of early complications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient has participated in the Informed Consent process and has signed the Informed Consent form previously approved by the Ethics Committee;
  • The patient diagnosis is one or more of the following:
  • Patient with advanced articular destruction generated by primary degenerative or post-traumatic arthrosis or rheumatoid arthritis;
  • Patient with avascular necrosis of the femoral head or fracture of the femoral neck;
  • Patient with congenital or acquired deformity;
  • Patient with failures of previous operations, like osteosynthesis, articular reconstruction, arthrodesis, hemi-arthroplasty or total arthroplasty.
  • The patient is willing and able to complete scheduled follow-up evaluations as described in the Patient Information Sheet;

排除标准

  • The patient should be excluded from the study if he/she meets any of the following criteria, which reflect the cemented acetabular cup contraindication for use:
  • Acute or chronic infections, local or systemic infections;
  • Serious muscular, neurological or vascular diseases affecting the concerned limb;
  • Any concomitant disease and dependence that might affect the implanted prosthesis;
  • Allergy to material;
  • Metal-on-metal systems: patients with renal impairment.
  • Patient's age<18
  • Female patients who are pregnant, nursing, or planning a pregnancy.

结局指标

主要结局

Clinical progression of Harris Hip Score (HHS) from baseline to 2 years after surgery

时间窗: 2 years Follow up

HHS ranges from 0 to 100, being 0 the worst and 100 the best conditions. HHS is reported as 90-100 for excellent results, 80-90 for good, 70-79 for fair, 60-69 for poor, and below 60 for a failed result. The outcome is considered satisfactory for values over 80

次要结局

  • Clinical progression of HOOS up to 2 years FU, compared to the baseline(6 weeks, 1 year and 2 years FU)
  • Change in TUG from preoperative up to 2 years FU(6 weeks, 1 year and 2 years FU)
  • Clinical progression of HHS up to 1 year FU, compared to the baseline(6 weeks, 1 year)
  • Implant survivorship (Kaplan-Meier estimate) at 2 years after surgery(2 years FU)
  • Radiographic evaluation and stability assessment of the implant up to 2 years FU(6 weeks, 1 year and 2 years FU)
  • Incidence of device-related AE/SAE up to 2 years of follow-up(6 weeks, 1 year and 2 years FU)

研究者

发起方
Limacorporate S.p.a
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验